Skip to main content
CME
NASDAQ Crypto Assets

CME Group Adjourns Shareholder Meeting Proposals Due to Class B Quorum Failure

Analysis by Arik Shkolnikov
Sentiment info
Negative
Importance info
7
Price
$302.37
Mkt Cap
$109.567B
52W Low
$257.17
52W High
$329.16
Market data snapshot near publication time

summarizeSummary

CME Group adjourned several proposals at its annual shareholder meeting due to a lack of quorum from Class B shareholders, signaling potential governance friction.


check_boxKey Events

  • Annual Meeting Adjournment

    Several proposals (Items 4-8) from the May 14, 2026 Annual Meeting were adjourned to June 9, 2026, due to a lack of quorum among Class B shareholders.

  • Class B Quorum Failure

    Individual Class B share classes (B-1, B-2, B-3, B-4) did not meet the required 33.3% quorum, with participation ranging from 24.16% to 33.12%.

  • Director Elections Approved

    Equity Director nominees were elected, and the appointment of Ernst & Young LLP as auditor was ratified, with Class A and B shareholders voting as a single class.

  • Executive Compensation Approved

    The advisory vote on executive compensation was approved.


auto_awesomeAnalysis

CME Group's annual meeting saw several key proposals adjourned until June 9, 2026, because Class B shareholders failed to meet quorum requirements. This delay in decision-making, particularly in the context of a prior proposal to eliminate Class B director election rights, highlights potential governance challenges and a lack of engagement or consensus among this shareholder class.

At the time of this filing, CME was trading at $302.37 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $109.6B. The 52-week trading range was $257.17 to $329.16. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CME - Latest Insights

CME
May 20, 2026, 2:31 PM EDT
Source: Reuters
Importance Score:
7
CME
May 19, 2026, 4:24 PM EDT
Filing Type: DEFA14A
Importance Score:
7
CME
May 19, 2026, 4:21 PM EDT
Filing Type: 8-K
Importance Score:
7
CME
May 18, 2026, 2:04 AM EDT
Source: Reuters
Importance Score:
7
CME
May 16, 2026, 3:14 AM EDT
Source: Wiseek News
Importance Score:
7
CME
May 15, 2026, 12:48 PM EDT
Source: The Block
Importance Score:
7
CME
May 15, 2026, 10:02 AM EDT
Source: Reuters
Importance Score:
8
CME
May 07, 2026, 9:27 PM EDT
Source: Reuters
Importance Score:
8
CME
May 07, 2026, 11:00 AM EDT
Source: Reuters
Importance Score:
8
CME
Apr 27, 2026, 4:43 PM EDT
Source: Wiseek News
Importance Score:
7